LEADERSHIP
Experienced Leadership. Focused Execution.
Herve Aloysius, PhD – Founder & Chief Scientific Officer
With more than 24 years of experience in DMPK, translational science, oncology drug development, and PSA-activated prodrug research, Dr. Aloysius brings rare depth to the convergence of biochemistry, pharmacology, and clinical strategy. He founded Innovex Discovery to advance a rigorous, biology-first approach to tumor-selective oncology.
Partner With Innovex Discovery.
We welcome conversations with biotechnology and pharmaceutical companies, investors, research organizations, and development partners interested in PSA-activated prodrugs and tumor-selective oncology.
